Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Elanco Animal Health: 3 Key Takeaways for Long-Term Investors

Elanco's pricing held firm in Q3 while rivals discounted, a choice that tests whether proprietary products can continue to win share without cutting prices.

  • Elanco's Q3 2026 revenue rose 11% to $1.265 billion
  • Gross debt reduced by $216M, net leverage below 3.0x EBITDA
  • Pricing power and product innovation drive revenue growth

More from Monday 9 November →